Price movement over the last 24 hours
Alcon AG vs Prudential Financial Inc — how do they compare? Alcon AG trades at $66.89 (market cap $32.69B), while Prudential Financial Inc trades at $112.71 (market cap $40.11B). The key difference: Prudential Financial Inc is the larger of the two by market cap, and Prudential Financial Inc pays the higher dividend (4.85%). Which is the better fit depends on your goals.
| ALC | PRU | |
|---|---|---|
Market Cap | $32.69B | $40.11B |
Sector | Health | Financials |
52-Week High | $92.22 | $118.72 |
52-Week Low | $62.02 | $92.00 |
Enterprise Value | $36.28B | $67.16B |
Dividend Yield | 0.54% | 4.85% |
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
PRU trades at $115.47, up 2.23% today, with a bullish technical signal and strong moving average support. The company reported a net income margin of 5.5% in 2025, with recent earnings beats in Q1 2026. Recent developments include expansion in India's life insurance market and new ETF launches by PGIM, highlighting growth initiatives.
Outlook remains positive due to solid profitability and strategic expansions, but risks include volatile cash flows and high debt levels. Analyst consensus is cautious with a hold-heavy rating, though the current price exceeds the $98.64 target, suggesting limited near-term upside amid steady operational performance.
Trailing returns across standard periods
Latest headlines on both assets
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →